TY - JOUR
T1 - Autologous hematopoietic stem cell transplantation in neuromyelitis optica
T2 - A registry study of the EBMT Autoimmune Diseases Working Party
AU - Greco, Raffaella
AU - Bondanza, Attilio
AU - Oliveira, Maria Carolina
AU - Badoglio, Manuela
AU - Burman, Joachim
AU - Piehl, Fredrik
AU - Hagglund, Hans
AU - Krasulova, Eva
AU - Simões, Belinda Pinto
AU - Carlson, Kristina
AU - Pohlreich, David
AU - Labopin, Myriam
AU - Saccardi, Riccardo
AU - Comi, Giancarlo
AU - Mancardi, Gian Luigi
AU - Bacigalupo, Andrea
AU - Ciceri, Fabio
AU - Farge, Dominique
PY - 2015/2/17
Y1 - 2015/2/17
N2 - Background: Neuromyelitis optica (NMO) is an inflammatory autoimmune disorder of the central nervoussystem, hallmarked by pathogenic anti-aquaporin 4 antibodies. NMO prognosis is worse comparedwith multiple sclerosis.Objective: The European Group for Blood and Marrow Transplantation (EBMT) Autoimmune DiseasesWorking Party (ADWP) conducted a retrospective survey to analyze disease outcome following autologousstem cell transplantation (ASCT).Methods: This retrospective multicenter study assessed the efficacy and safety of ASCT in 16 patientssuffering from refractory NMO reported to the EBMT registry between 2001 and 2011.Results: Fifteen patients were successfully mobilized with cyclophosphamide (Cy) and G-CSF, one withG-CSF alone. All patients received an unmanipulated autologous peripheral blood stem cell graft, afterconditioning with BEAM plus anti-thymocyte globulin (ATG, n = 9 patients), thiotepa-Cy (n = 3) or Cy(200 mg/kg) plus ATG (n = 4).After a median follow-up of 47 months, three of 16 cases were progression and treatment free, while inthe remaining 13 patients further treatments were administered for disability progression or relapse afterASCT. Altogether, relapse-free survival at three and five years was 31% and 10%, respectively, whileprogression-free survival remained 48% at three and five years.Conclusions: In these NMO patients, highly resistant to conventional treatment, ASCT allows for temporarycontrol of the disease, despite a tendency to progress or relapse in the long term.
AB - Background: Neuromyelitis optica (NMO) is an inflammatory autoimmune disorder of the central nervoussystem, hallmarked by pathogenic anti-aquaporin 4 antibodies. NMO prognosis is worse comparedwith multiple sclerosis.Objective: The European Group for Blood and Marrow Transplantation (EBMT) Autoimmune DiseasesWorking Party (ADWP) conducted a retrospective survey to analyze disease outcome following autologousstem cell transplantation (ASCT).Methods: This retrospective multicenter study assessed the efficacy and safety of ASCT in 16 patientssuffering from refractory NMO reported to the EBMT registry between 2001 and 2011.Results: Fifteen patients were successfully mobilized with cyclophosphamide (Cy) and G-CSF, one withG-CSF alone. All patients received an unmanipulated autologous peripheral blood stem cell graft, afterconditioning with BEAM plus anti-thymocyte globulin (ATG, n = 9 patients), thiotepa-Cy (n = 3) or Cy(200 mg/kg) plus ATG (n = 4).After a median follow-up of 47 months, three of 16 cases were progression and treatment free, while inthe remaining 13 patients further treatments were administered for disability progression or relapse afterASCT. Altogether, relapse-free survival at three and five years was 31% and 10%, respectively, whileprogression-free survival remained 48% at three and five years.Conclusions: In these NMO patients, highly resistant to conventional treatment, ASCT allows for temporarycontrol of the disease, despite a tendency to progress or relapse in the long term.
KW - Autologous stem cell transplantation
KW - Disease outcome
KW - Neuromyelitis optica
UR - http://www.scopus.com/inward/record.url?scp=84923078724&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84923078724&partnerID=8YFLogxK
U2 - 10.1177/1352458514541978
DO - 10.1177/1352458514541978
M3 - Article
C2 - 25078274
AN - SCOPUS:84923078724
VL - 21
SP - 189
EP - 197
JO - Multiple Sclerosis
JF - Multiple Sclerosis
SN - 1352-4585
IS - 2
ER -